OMEGA Study Group

EN / JP

🚀About

The OMEGA Study Group was founded in 2023 to research, develop, and disseminate technology that can help people with diabetes or pre-diabetes to lead better lives. We aim to achieve this by combining minimally or non-invasive blood glucose monitoring technology that uses a blood glucose surrogate biomarker called ‘glycated albumin’ with communication technology such as smartphone applications. We support the 'power to live a healthy life' that is inherent in everyone.

Constitution (Japanese)

230513_OMEGA Study Group会則_第1版.pdf

👥Members

Team Member

🩺Study

Ongoing clinical study

The digital intervention of a glycated albumin (GA) self-monitoring system for patients with type 2 diabetes: a randomized, open-label, non-intervention group controlled, single-center clinical study

Publication

Aihara M, Irie T, Yasukawa K, et al. Development of a high-performance liquid chromatographic glycated albumin assay using finger-prick blood samples [published online ahead of print, 2023 Feb 28]. Clin Chim Acta . 2023;542:117272. doi:10.1016/j.cca.2023.117272
Aihara M, Jinnouchi H, Yoshida A, et al. Evaluation of glycated albumin levels in tears and saliva as a marker in patients with diabetes mellitus [published online ahead of print, 2023 Mar 22]. Diabetes Res Clin Pract. 2023;110637. doi:10.1016/j.diabres.2023.110637